Smoking at diagnosis is an independent prognostic factor for cancer-specific survival in head and neck cancer: Findings from a large, population-based study

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 11, 2014, Pages 2579-2590

  Sharp, Linda ^a   McDevitt, Joseph ^a   Carsin, Anne Elie ^b   Brown, Christopher ^a   Comber, Harry ^a  

^a NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH TUMOR; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PHARYNX CANCER; PROGNOSTIC ASSESSMENT; PROPORTIONAL HAZARDS MODEL; SALIVARY GLAND TUMOR; SMOKING; SMOKING CESSATION; SQUAMOUS CELL CARCINOMA; ADVERSE EFFECTS; HEAD AND NECK NEOPLASMS; MORTALITY; PROGNOSIS; RISK FACTOR;

AGED; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SMOKING;

EID: 84920130324     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0311     Document Type: Article

References (79)

1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Personal habits and indoor combustions. Volume 100 E. A reviewof human carcinogens. IARC Monogr Eval Carcinog Risks Hum 2012;100:1-538.
2. Hashibe M, Brennan P, Chuang SC, Boccia S, Castellsague X, Chen C, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev 2009;18:541-50.
3. Parkin DM. 2. Tobacco-attributable cancer burden in the UK in 2010. Br J Cancer 2011;105 Suppl 2:S6-13.
4. Hashibe M, Hunt J, Wei M, Buys S, Gren L, Lee YC. Tobacco, alcohol, body mass index, physical activity, and the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort. Head Neck 2013;35:914-22.
5. US Department of Health and Human Services. The health consequences of smoking-50 years of progress: a report of the Surgeon General. Rockville, MD: US Department of Health and Human Services; 2014.
6. Lassig AA, Yueh B, JosephAM. The effect of smoking on perioperative complications in head and neck oncologic surgery. Laryngoscope 2012;122:1800-8.
7. Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, et al., Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. New Eng J Med 1993;328:159-63.
8. Fountzilas G, Kosmidis P, Avramidis V, Nikolaou A, Kalogera-Fountzila A, Makrantonakis P, et al. Long-term survival data and prognostic factors of a complete response to chemotherapy in patients with head and neck cancer treated with platinum-based induction chemotherapy: a Hellenic co-operative oncology group study. Med Pediatr Oncol 1997;28:401-10.
9. Boffetta P, Merletti F, Faggiano F, Migliaretti G, Ferro G, Zanetti R, et al. Prognostic factors and survival of laryngeal cancer patients from Turin, Italy. A population-based study. Am J Epidemiol 1997; 145:1100-5.
10. Agarwal JP, Mallick I, Bhutani R, Ghosh-Laskar S, Gupta T, Budrukkar A, et al. Prognostic factors in oropharyngeal cancer- analysis of 627 cases receiving definitive radiotherapy. Acta Oncol 2009;48:1026-33.
11. Duffy SA, Ronis DL, McLean S, Fowler KE, Gruber SB, Wolf GT, et al. Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. J Clin Oncol 2009;27:1969-75.
12. Hilgert E, Bergmann C, Fichtner A, Gires O, Issing W. Tobacco abuse relates to significantly reduced survival of patients with oropharyngeal carcinomas. Eur J Cancer Prev 2009;18:120-6.
13. Mayne ST, Cartmel B, Kirsh V, Goodwin WJ. Alcohol and tobacco use prediagnosis and postdiagnosis, and survival in a cohort of patients with early stage cancers of the oral cavity, pharynx, and larynx. Cancer Epidemiol Biomarkers Prev 2009;18:3368-74.
14. Kawakita D, Hosono S, Ito H, Oze I, Watanabe M, Hanai N, et al. Impact of smoking status on clinical outcome in oral cavity cancer patients. Oral Oncol 2012;48:186-91.
15. Sethi S, Ali-Fehmi R, Franceschi S, Struijk L, van Doorn LJ, Quint W, et al. Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study. Int J Cancer 2012;131:1179-86.
16. Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012;30:2102-11.
17. Verschuur HP, Irish JC, O'Sullivan B, Goh C, Gullane PJ, Pintilie M. A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck. Laryngoscope 1999;109:249-58.
18. Rosenquist K, Wennerberg J, Annertz K, Schildt EB, Hansson BG, Bladström A, et al. Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors. Acta Otolaryngol 2007;127:980-7.
19. Lopez RV, Zago MA, Eluf-Neto J, Curado MP, Daudt AW, da Silva-Junior WA, et al. Education, tobacco smoking, alcohol consumption, and IL-2 and IL-6 gene polymorphisms in the survival of head and neck cancer. Braz J Med Biol Res 2011;44:1006-12.
20. Mallaina P, Lionis C, Rol H, Imperiali R, Burgess A, Nixon M, et al. Smoking cessation and the risk of cardiovascular disease outcomes predicted from established risk scores: results of the cardiovascular risk assessment among smokers in primary care in Europe (CVASPIRE) study. BMC Public Health 2013;13:362.
21. O'Brien K, Comber H, Sharp L. Completeness of case ascertainment at the Irish National Cancer Registry. Ir J Med Sci 2014;183:219-24.
22. Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst 2010;102:1584-98.
23. Sobin LH, Wittekind C. TNM: Classification of malignant tumours (UICC). 5th ed. New York: Wiley-Blackwell; 1997.
24. Kelly A, Teljeur C. The national deprivation index for health and health services research. Small area health research unit (SAHRU). Dublin: Trinity College Dublin; 2007.
25. Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner MD. Cancer survival among adults: U.S. SEER program, 1988 -2001. Patient and tumor characteristics. SEER survival monograph. Report No.: NIH 07-6215. Bethesda MD: National Cancer Institute SEER Program; 2007.
26. Carlin JB, Galati JC, Royston P. A new framework for managing and analyzing multiply imputed data in Stata. Stat J 2014;8:49-67.
27. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011;30:377-99.
28. van der Heijden GJ, Donders AR, Stijnen T, Moons KG. Imputation of missing values is superior to complete case analysis and the missing indicator method in multivariable diagnostic research: a clinical example. J Clin Epidemiol 2006;59:1102-9.
29. White IR, Carlin JB. Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med 2010;29:2920-31.
30. Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what is it and how does it work? Int J Methods Psychiatr Res 2011;20:40-9.
31. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994:515-26.
32. Rubin DB. Multiple imputation for non-response in surveys. New York: Wiley; 1987.
33. Gronkjaer M, Eliasen M, Skov-Ettrup LS, Tolstrup JS, Christiansen AH, Mikkelsen SS, et al. Preoperative smoking status and postoperative complications: a systematic review and meta-analysis. Ann Surg 2014;259:52-71.
34. Browman GP, Mohide EA, Willan A,Hodson I,Wong G, Grimard L, et al. Association between smoking during radiotherapy and prognosis in head and neck cancer: a follow-up study. Head Neck 2002;24:1031-7.
35. Hoff CM, Grau C, Overgaard J. Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma - a prospective study. Radiother Oncol 2012;103:38-44.
36. Kowalski LP, Carvalho AL. Natural history of untreated head and neck cancer. Eur J Cancer 2000;36:1032-7.
37. Maxwell JH, Kumar B, Feng FY, Worden FP, Lee JS, Eisbruch A, et al. Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res 2010;16:1226-35.
38. Wang W, Han S, Yao Z, Li X, Huang P, Zhang M, et al. A study of epidemiologic and recurrence factors of oral cancer. J Oral Maxillofac Surg 2012;70:2205-10.
39. McBride SM, Ali NN, Margalit DN, Chan AW. Active tobacco smoking and distant metastasis in patients with oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2012;84:183-8.
40. Chuang SC, Scelo G, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer 2008;123:2390-6.
41. Silverman S, Gorsky M, Greenspan D. Tobacco usage in patients with head and neck carcinomas: a follow-up study on habit changes and second primary oral/oropharyngeal cancers. J Am Dent Assoc 1983;106:33-5.
42. Do KA, Johnson MM, Doherty DA, Lee JJ, Wu XF, Dong Q, et al. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control 2003;14:131-8.
43. Rennemo E, Zatterstrom U, Boysen M. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases. Laryngoscope 2008;118:1350-6.
44. Schwartz LH, Ozsahin M, Zhang GN, Touboul E, De Vataire F, Andolenko P, et al. Synchronous and metachronous head and neck carcinomas. Cancer 1994;74:1933-8.
45. Yanbaeva D, Dentener M, Creutzberg EC, Wesseling G, Wouters E. Systemic effects of smoking. Chest 2007;131:1557-66.
46. O'Byrne K, Dalgleish A, Browning M, Steward W, Harris A. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer 2000;36:151-69.
47. Wang F, Arun P, Friedman J, Chen Z, Van Waes C. Current and potential inflammation targeted therapies in head and neck cancer. Curr Opin Pharmacol 2009;9:389-95.
48. Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, Wolf GT, et al. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer 2008;113:750-7.
49. Duffy SA, Teknos T, Taylor JM, Fowler KE, Islam M, Wolf GT, et al. Health behaviors predict higher interleukin-6 levels among patients newly diagnosed with head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2013;22:374-81.
50. Lee J, Taneja V, Vassallo R. Cigarette smoking and inflammation: cellular and molecular mechanisms. J Dent Res 2012;91:142-9.
51. Fracasso M, Doria D, Franceschetti P, Perbellini L, Romeo L. DNA damage and repair capacity by comet assay in lymphocytes of whitecollar active smokers and passive smokers (non- and ex-smokers) at workplace. Toxicol Lett 2006;167:131-41.
52. Jun HJ, Ahn MJ, Kim HS, Yi SY, Han J, Lee SK, et al.ERCC1expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation. Br J Cancer 2008;99:167-72.
53. Vaezi A, Wang X, Buch S, Gooding W, Wang L, Seethala RR, et al. XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck. Clin Cancer Res 2011;17:5513-22.
54. Bauman JE, Austin MC, Schmidt R, Kurland BF, Vaezi A, Hayes DN, et al. ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial. Br J Cancer 2013;109:2096-105.
55. Worsley A, Wang WC, Hunter W. The relationships between eating habits, smoking and alcohol consumption, and body mass index among baby boomers. Appetite 2012;58:74-80.
56. Nguyen TV, Yueh B. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas. Cancer 2002;95:553-62.
57. Dikshit RP, Boffetta P, Bouchardy C, Merletti F, Crosignani P, Cuchi T, et al. Lifestyle habits as prognostic factors in survival of laryngeal and hypopharyngeal cancer: a multicentric European study. Int J Cancer 2005;117:992-5.
58. Arthur AE, Peterson KE, Rozek LS, Taylor JM, Light E, Chepeha DB, et al. Pretreatment dietary patterns, weight status, and head and neck squamous cell carcinoma prognosis. Am J Clin Nutr 2013;97:360-8.
59. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012;307:693-703.
60. O'Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol 2012;48:1191-201.
61. Misono S, Marmor S, Yueh B, Virnig BA. Treatment and survival in 10,429 patients with localized laryngeal cancer: a population-based analysis. Cancer 2014;120:1810-7.
62. Tiwana MS, Wu J, Hay J, Wong F, Cheung W, Olson RA. 25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province. Oral Oncol 2014;50:651-6.
63. Andersen ZJ, Lassen CF, Clemmensen IH. Social inequality and incidence of and survival from cancers of the mouth, pharynx and larynx in a population-based study in Denmark, 1994-2003. Eur J Cancer 2008;44:1950-61.
64. Lee CC, Chien SH, Hung SK, Yang WZ, Su YC, Nadler RB. Effect of individual and neighborhood socioeconomic status on oral cancer survival. Oral Oncol 2012;48:253-61.
65. McDonald JT, Johnson-Obaseki S, Hwang E, Connell C, Corsten M. The relationship between survival and socio-economic status for head and neck cancer in Canada. J Otolaryngol Head Neck Surg 2014;43:2.
66. Aizer AA, Chen MH, McCarthy EP, Mendu ML, Koo S, Wilhite TJ, et al. Marital status and survival in patients with cancer. J Clin Oncol 2013;31:3869-76.
67. Osborne C, Ostir GV, Du X, PeekMK, Goodwin JS. The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer. Breast Cancer Res Treat 2005;93:41-7.
68. Baine M, Sahak F, Lin C, Chakraborty S, Lyden E, Batra SK. Marital status and survival in pancreatic cancer patients: a SEER based analysis. PLoS ONE 2011;6:e21052.
69. Fossa SD, Cvancarova M, Chen L, Allan AL, Oldenburg J, Peterson DR, et al. Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patients. J Clin Oncol 2011;29:963-70.
70. Goodwin JS, Hunt WC, Key CR, Samet JM. The effect of marital status on stage, treatment, and survival of cancer patients. JAMA 1987;258:3125-30.
71. Cronin-Fenton DP, Sharp L, Deady S, Comber H. Treatment and survival for Non-Hodgkin's Lymphoma: influence of histological subtype, age, and other factors in a population-based study (1999-2001). Eur J Cancer 2006;42:2786-93.
72. Carsin AE, Sharp L, Cronin-Fenton DP, Céeilleachair AO, Comber H. Inequity in colorectal cancer treatment and outcomes: a population-based study. Br J Cancer 2008;99:266-74.
73. Cronin-Fenton DP, Sharp L, Carsin AE, Comber H. Patterns of care and effects on mortality for cancers of the oesophagus and gastric cardia: a population-based study. Eur J Cancer 2007;43:565-75.
74. Sharp L, Carsin AE, Cronin-Fenton DP, O'Driscoll D, Comber H. Is there under-treatment of pancreatic cancer? Evidence from a population-based study in Ireland. Eur J Cancer 2009;45:1450-9.
75. Wong J, Lam DP, Abrishami A, Chan MT, Chung F. Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis. Can J Anaesth 2012;59:268-79.
76. Warnakulasuriya S. Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncol 2010;46:407-10.
77. Warren GW, Kasza KA, Reid ME, Cummings KM, Marshal JR. Smoking at diagnosis and survival in cancer patients. Int J Cancer 2013;132:401-10.
78. National Cancer Registry/Northern Ireland Cancer Registry. All-Ireland cancer atlas 1995-2007. Cork/Belfast: 2011.
79. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol 2004;57:597-609.